NCT00212589View on ClinicalTrials.gov

Patients Preference for Oral or i.v. Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

April 30, 2004

Conditions
Colorectal Cancer
Interventions
DRUG

Capecitabine

DRUG

Fluorouracil + folinic acid

Trial Locations (4)

5000

Department of Oncology, Odense University Hospital, Odense

6400

Department of Oncology, Sonderborg Hospital, Sønderborg

6700

Department of Oncology, Esbjerg Hospital, Esbjerg

7100

Department of Oncology, Vejle Hospital, Vejle

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT00212589 - Patients Preference for Oral or i.v. Therapy | Biotech Hunter | Biotech Hunter